Gary F Baxter

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Ischemia Reperfusion Injury

Blood Brain Barrier

Health Insurance

Top Venues

Pharmacological reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Ferdinandy, Ioanna Andreadou, Gary F Baxter, Hans Erik Botker, Sean M Davidson, Dobromir Dobrev, Bernard J Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J Zuurbier, Derek J Hausenloy, Rainer Schulz
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological reviews 75 (1) (2022)
Peter Ferdinandy, Ioanna Andreadou, Gary F Baxter, Hans Erik Botker, Sean M Davidson, Dobromir Dobrev, Bernard J Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J Zuurbier, Derek J Hausenloy, Rainer Schulz
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological reviews 75 (1) (2022)
Peter Ferdinandy, Ioanna Andreadou, Gary F Baxter, Hans Erik Botker, Sean M Davidson, Dobromir Dobrev, Bernard J Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J Zuurbier, Derek J Hausenloy, Rainer Schulz
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological reviews 75 (1) (2022)
Peter Ferdinandy, Ioanna Andreadou, Gary F Baxter, Hans Erik Botker, Sean M Davidson, Dobromir Dobrev, Bernard J Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J Zuurbier, Derek J Hausenloy, Rainer Schulz
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological reviews 75 (1) (2022)